Longevity Life Sciences named Start-up of the Year at the 2026 NutraIngredients-Asia Awards
Longevity Life Sciences has been named Start-up of the Year at the 2026 NutraIngredients-Asia Awards, recognising the company’s emergence within the Asia-Pacific nutrition and health industry.
The award marks an important milestone for LLS as it continues to build an integrated cellular health platform spanning ingredient development, regulatory strategy, clinical research and global commercialisation.
Founded in Australia, LLS works with research, scientific and industry partners across the Asia-Pacific region to identify and develop compounds with the potential to support cellular health, and to build the scientific and regulatory foundations required for their responsible commercialisation.
“This recognition means a great deal to us because it reflects what our entire team and our partners have been building together,” said Sally Panton, Co-founder and CEO of Longevity Life Sciences.
“We set out to create a life sciences company capable of bridging emerging science with rigorous research, regulatory pathways and real-world commercialisation. There is an enormous amount still ahead of us, but this is a wonderful moment to recognise how far that collective effort has already taken us.”
The NutraIngredients-Asia Awards recognise excellence and innovation across the nutrition, health and wellness industry throughout the Asia-Pacific region.
For LLS, the award follows a period of significant scientific, regulatory and commercial development as the company continues to expand its cellular health platform and international partnerships.
